Christos J Petropoulos

Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B

Yang Liu, Terri Wrin, Colombe Chappey, 2005, Journal of Virology.

A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase

Sebastian Bonhoeffer, Colombe Chappey, Trevor Hinkley, 2011, Nature Genetics.

Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.

Colombe Chappey, C. Petropoulos, C. Chappey, 2003, The Journal of infectious diseases.

Assessing chemokine co-receptor usage in HIV

Eoin Coakley, C. Petropoulos, J. Whitcomb, 2005, Current opinion in infectious diseases.

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

Terri Wrin, E. Rosenberg, F. Pereyra, 2008, The Journal of infectious diseases.

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.

Rebecca Hoh, Torsten B Neilands, Robert M Grant, 2005, The Journal of infectious diseases.

Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother–infant pairs

Wei Huang, Neil Parkin, Eric Stawiski, 2009, AIDS.

Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants.

Wei Huang, Akbar Ali, Celia A Schiffer, 2017, Journal of medicinal chemistry.

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.

Yang Liu, Terri Wrin, Sergei L. Kosakovsky Pond, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response

Terri Wrin, Rebecca Hoh, Robert M Grant, 2003, AIDS.